More: Digestive Disease Week (DDW) 2008

DDW 2008: Select Topics in GI Oncology -- Issues in CRC and Applications of EUS CME

May 17 - 22, 2008, San Diego, California

Author Information and Disclosures

This activity is not sanctioned by, nor a part of, Digestive Disease Week. Conference news does not receive grant support and is produced independently.

Release Date: June 30, 2008; Valid for credit through June 30, 2009

Credits Available
Physicians - maximum of 1.5 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of Digestive Disease Week. These materials and the related activity are not sanctioned by Digestive Disease Week or the commercial supporter of the conference and do not constitute an official part of that conference.

Copyright © 2008 Medscape.
Medscape
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Explore current issues regarding screening and surveillance of patients with colorectal cancer, including the impact of withdrawal times and other factors on adenoma detection
  2. Summarize the latest concepts in the approach to colorectal cancer as they influence strategies of clinical management and screening and affect clinical outcome, including issues in bowel preparation and technical performance
  3. Discuss current applications of EUS in the setting of GI and related cancers. Learning Objectives
Authors and Disclosures

Douglas K. Rex, MD, FACG
Disclosure: Douglas K. Rex, MD, FACG, has disclosed that he has served on the speaker's bureau of CB Fleet, Olympus, Salix, and TAP. Dr. Rex has also disclosed that he has received research support from CB Fleet, Given Imaging, MGI Pharma, Olympus, and Salix. Dr. Rex has also disclosed that he has served on the scientific advisory boards of American BioOptics, Avantis Medical Systems, CB Fleet, GI View, Given Imaging, and Salix.


Charles J. Lightdale, MD
Disclosure: Charles J. Lightdale, MD, has disclosed that he has received grants for clinical research from Barrx and Boston Scientific. Dr. Lightdale has also disclosed that he has served as an advisor or consultant to Cook and Olympus. He has also disclosed that he has received speaker honoraria from Barrx.


Maria L. Gaiso, PhD
Disclosure: Maria L. Gaiso, PhD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.